# Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

> **NCT07090174** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Weill Medical College of Cornell University** · enrollment: 27 (estimated)

## Conditions studied

- HPV Associated Cancers
- HIV (Human Immunodeficiency Virus)
- Anal Cancer
- Cervical Cancer
- HPV 16 Infection

## Interventions

- **BIOLOGICAL:** PDS0101

## Key facts

- **NCT ID:** NCT07090174
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-20
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2025-10-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07090174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07090174, "Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07090174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*